Q3 2022

Protected: Newsletter

This content is password protected. To view it please enter your password below:

IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.